Cardiomyopathy - Pipeline Review, H2 2015

1
Cardiomyopathy - Pipeline Review, H2 2015
(Type, Mode of action, Crop Type and Geography) -
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2013 -
2020
TELEPHONE [phone]E-MAIL
sales_at_researchbeam.com
Published on Oct 2014
2


Report Overview

• Scope
• The report provides a snapshot of the global
  therapeutic landscape of Cardiomyopathy
• The report reviews key pipeline products under
  drug profile section which includes, product
  description, MoA and RD brief, licensing and
  collaboration details other developmental
  activities
• The report reviews key players involved in the
  therapeutics development for Cardiomyopathy and
  enlists all their major and minor projects
• The report summarizes all the dormant and
  discontinued pipeline projects
• A review of the Cardiomyopathy products under
  development by companies and universities/research
  institutes based on information derived from
  company and industry-specific sources
• Pipeline products coverage based on various
  stages of development ranging from
  pre-registration till discovery and undisclosed
  stages
• A detailed assessment of monotherapy and
  combination therapy pipeline projects
• Coverage of the Cardiomyopathy pipeline on the
  basis of target, MoA, route of administration and
  molecule type
• Latest news and deals relating related to
  pipeline products
• Read More At http//www.researchbeam.com/cardiom
  yopathy-pipeline-review-h2-2015-market

3


Table of Content
Table of Contents 2List of Tables 6List of
Figures 7Introduction 8Global Markets Direct
Report Coverage 8Cardiomyopathy Overview
9Therapeutics Development 10Pipeline Products
for Cardiomyopathy - Overview 10Pipeline
Products for Cardiomyopathy - Comparative
Analysis 11Cardiomyopathy - Therapeutics under
Development by Companies 12Cardiomyopathy -
Therapeutics under Investigation by
Universities/Institutes 14Cardiomyopathy -
Pipeline Products Glance 15Clinical Stage
Products 15Early Stage Products 16Unknown Stage
Products 17Cardiomyopathy - Products under
Development by Companies 18Cardiomyopathy -
Products under Investigation by
Universities/Institutes 19Cardiomyopathy -
Companies Involved in Therapeutics Development
20Array BioPharma Inc. 20Bioheart, Inc.
21Gilead Sciences, Inc. 22
4


Report Overview
Reasons to buy - Provides strategically
significant competitor information, analysis, and
insights to formulate effective RD
development strategies - Identify emerging
players with potentially strong product portfolio
and create effective counter strategies to
gain competitive advantage - Develop strategic
initiatives by understanding the focus areas of
leading companies - Identify and understand
important and diverse types of therapeutics under
development for Cardiomyopathy - Plan mergers and
acquisitions effectively by identifying key
players of the most promising pipeline - Devise
corrective measures for pipeline projects by
understanding Cardiomyopathy pipeline depth and
focus of Indication therapeutics - Develop and
design in-licensing and out-licensing strategies
by identifying prospective partners with the most
attractive projects to enhance and expand
business potential and Scope - Modify the
therapeutic portfolio by identifying discontinued
projects and understanding the factors that drove
them from pipeline Enquire At
http//www.researchbeam.com/cardiomyopathy-pipelin
e-review-h2-2015-market/enquire-about-report
5



FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/cardiomyopathy-pipelin
e-review-h2-2015-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone] DIRECT 1 (503)
894-6022E-MAIL sales_at_researchbeam.com